JP2022526553A5 - - Google Patents
Info
- Publication number
- JP2022526553A5 JP2022526553A5 JP2021557759A JP2021557759A JP2022526553A5 JP 2022526553 A5 JP2022526553 A5 JP 2022526553A5 JP 2021557759 A JP2021557759 A JP 2021557759A JP 2021557759 A JP2021557759 A JP 2021557759A JP 2022526553 A5 JP2022526553 A5 JP 2022526553A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- substituted
- pharmaceutically acceptable
- acceptable salt
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1904375.1 | 2019-03-29 | ||
| GBGB1904375.1A GB201904375D0 (en) | 2019-03-29 | 2019-03-29 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| PCT/EP2020/058061 WO2020200898A1 (en) | 2019-03-29 | 2020-03-24 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526553A JP2022526553A (ja) | 2022-05-25 |
| JP2022526553A5 true JP2022526553A5 (https=) | 2023-04-06 |
Family
ID=66442789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557759A Pending JP2022526553A (ja) | 2019-03-29 | 2020-03-24 | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220296573A1 (https=) |
| EP (1) | EP3947374A1 (https=) |
| JP (1) | JP2022526553A (https=) |
| KR (1) | KR20210143905A (https=) |
| CN (1) | CN113677678A (https=) |
| AU (1) | AU2020252900A1 (https=) |
| BR (1) | BR112021019099A2 (https=) |
| CA (1) | CA3134732A1 (https=) |
| GB (1) | GB201904375D0 (https=) |
| IL (1) | IL286688A (https=) |
| MX (1) | MX2021011574A (https=) |
| PH (1) | PH12021552377A1 (https=) |
| SG (1) | SG11202110643YA (https=) |
| WO (1) | WO2020200898A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA54755A (fr) * | 2019-01-18 | 2021-11-24 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
| KR20230059584A (ko) | 2021-10-26 | 2023-05-03 | 주식회사 엘지에너지솔루션 | 전극 조립체의 제조방법 |
| WO2023098857A1 (zh) * | 2021-12-03 | 2023-06-08 | 武汉人福创新药物研发中心有限公司 | Irak4抑制剂及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1657242A4 (en) * | 2003-08-15 | 2008-10-29 | Banyu Pharma Co Ltd | imidazopyridine |
| JPWO2005108399A1 (ja) * | 2004-05-10 | 2008-03-21 | 萬有製薬株式会社 | イミダゾピリジン化合物 |
| US9169260B2 (en) * | 2011-03-22 | 2015-10-27 | Merck Sharp & Dohme Corp. | Amidopyrazole inhibitors of interleukin receptor-associated kinases |
| RU2675818C2 (ru) * | 2013-03-14 | 2018-12-25 | Галапаго Нв | Новые соединения и фармацевтические композиции, их содержащие, для лечения воспалительных расстройств |
| EP3092226B1 (en) * | 2014-01-10 | 2019-03-13 | Aurigene Discovery Technologies Limited | Indazole compounds as irak4 inhibitors |
| CN108473498B (zh) * | 2015-12-22 | 2021-11-02 | 豪夫迈·罗氏有限公司 | 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物 |
| WO2018060174A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2018060072A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| CN110835338A (zh) * | 2018-08-17 | 2020-02-25 | 浙江海正药业股份有限公司 | 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途 |
| MA54755A (fr) * | 2019-01-18 | 2021-11-24 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 |
| GB201904373D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
-
2019
- 2019-03-29 GB GBGB1904375.1A patent/GB201904375D0/en not_active Ceased
-
2020
- 2020-03-24 KR KR1020217035256A patent/KR20210143905A/ko not_active Withdrawn
- 2020-03-24 BR BR112021019099A patent/BR112021019099A2/pt not_active Application Discontinuation
- 2020-03-24 MX MX2021011574A patent/MX2021011574A/es unknown
- 2020-03-24 AU AU2020252900A patent/AU2020252900A1/en not_active Abandoned
- 2020-03-24 US US17/599,447 patent/US20220296573A1/en not_active Abandoned
- 2020-03-24 JP JP2021557759A patent/JP2022526553A/ja active Pending
- 2020-03-24 CA CA3134732A patent/CA3134732A1/en active Pending
- 2020-03-24 SG SG11202110643YA patent/SG11202110643YA/en unknown
- 2020-03-24 EP EP20714521.0A patent/EP3947374A1/en not_active Withdrawn
- 2020-03-24 WO PCT/EP2020/058061 patent/WO2020200898A1/en not_active Ceased
- 2020-03-24 CN CN202080026038.XA patent/CN113677678A/zh active Pending
- 2020-03-24 PH PH1/2021/552377A patent/PH12021552377A1/en unknown
-
2021
- 2021-09-26 IL IL286688A patent/IL286688A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526553A5 (https=) | ||
| JP2022023958A5 (https=) | ||
| KR20190053836A (ko) | 면역조절제 화합물 | |
| JP2021534124A5 (https=) | ||
| JP2016518385A5 (https=) | ||
| JP2014507455A5 (https=) | ||
| JP2012521994A5 (https=) | ||
| JP2016515096A5 (https=) | ||
| JP2015509535A5 (https=) | ||
| JP2014506907A5 (https=) | ||
| KR102906376B1 (ko) | 항혈소판 약물 및 이의 용도 | |
| JPH0314028B2 (https=) | ||
| JP2013512277A5 (https=) | ||
| JP2011529964A5 (https=) | ||
| JP2014500870A5 (https=) | ||
| JP2020505440A5 (https=) | ||
| JP2013533291A5 (https=) | ||
| CA2679232A1 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
| JP2013533883A5 (https=) | ||
| JP2016532669A5 (https=) | ||
| JP2019513745A5 (https=) | ||
| CA2143744A1 (en) | Diaryl piperazinoacetamide compounds as antimuscarinic agents | |
| JP7200005B2 (ja) | 飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途 | |
| JP2022526364A5 (https=) | ||
| JP2020511536A5 (https=) |